Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas

OBJECTIVE: Differences in gastric cancer (GC) clinical outcomes between patients in Asian and non-Asian countries has been historically attributed to variability in clinical management. However, recent international Phase III trials suggest that even with standardised treatments, GC outcomes differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Suling J, Gagnon-Bartsch, Johann A, Tan, Iain Beehuat, Earle, Sophie, Ruff, Louise, Pettinger, Katherine, Ylstra, Bauke, van Grieken, Nicole, Rha, Sun Young, Chung, Hyun Cheol, Lee, Ju-Seog, Cheong, Jae Ho, Noh, Sung Hoon, Aoyama, Toru, Miyagi, Yohei, Tsuburaya, Akira, Yoshikawa, Takaki, Ajani, Jaffer A, Boussioutas, Alex, Yeoh, Khay Guan, Yong, Wei Peng, So, Jimmy, Lee, Jeeyun, Kang, Won Ki, Kim, Sung, Kameda, Yoichi, Arai, Tomio, zur Hausen, Axel, Speed, Terence P, Grabsch, Heike I, Tan, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Stomach
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680172/
https://www.ncbi.nlm.nih.gov/pubmed/25385008
http://dx.doi.org/10.1136/gutjnl-2014-308252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680172/
https://www.ncbi.nlm.nih.gov/pubmed/25385008
http://dx.doi.org/10.1136/gutjnl-2014-308252

Ejemplares similares